Open an account

Omada Health

OMDA · NASDAQ

$19.34+$1.28 (+7.09%)TodayMarket closed ·
Prev close $18.06

About OMDA

Omada Health, Inc. engages in the provision of digital health services. The company is headquartered in South San Francisco, California and currently employs 916 full-time employees. The company went IPO on 2025-06-06. The firm has one operating segment, namely all virtual care program product offerings. The Company’s member-facing platform is designed to offer an integrated experience that encompasses the full range of direct interactions. The company offers range of programs like Omada for Prevention & Weight Health, Omada for Diabetes, Omada for Hypertension, Omada for musculoskeletal (MSK), and Omada GLP-1 Care Tracks. Its Omada for Prevention & Weight Health programs focus on prediabetes and weight management, two critical elements of preventing diabetes and heart disease. Its Omada for Diabetes program is designed to help members with type 1 or type 2 diabetes achieve stable blood glucose levels and meet and reach their goals for reducing hemoglobin A1C. Its Omada for Hypertension is designed to help reduce members blood pressure and help them maintain healthy blood pressure.

Employees
916
Headquarters
South San Francisco, California
Listed
Jun 6, 2025
Sector
Health Care
Industry
Health Care Providers & Services
Website
omadahealth.com

OMDA key statistics

Market cap
1.18B
Price-earnings ratio
0.00
Dividend yield
—
Average volume
1.18M
Volume
1.22M
Open price
$18.06
High today
$19.36
Low today
$18.05
52 Week high
$26.92
52 Week low
$10.28

Omada Health (OMDA) at a glance

Omada Health (OMDA) last traded at $19.34, with a market cap of 1.18B and a price-to-earnings ratio of 0.00.

Today the stock has traded between $18.05 and $19.36. The current price is 7.1% above the day's low and 0.1% below its high.

Volume so far is 1.22M shares, in line with the average of 1.18M shares a day.

Over the past year Omada Health has ranged from $10.28 to $26.92, and now sits 54% of the way up that range.

Omada Health met or beat analyst EPS estimates in 5 of the last 5 quarters. In Q2 FY26 it reported $0.08 per share against an estimate of -$0.0163.

The average analyst price target is $28.84, 49.1% above the current price, from 14 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

86%of 14 analyst ratings say Buy
  • Buy85.7%
  • Hold14.3%
  • Sell0.0%
Price target · 14 analystsAvg $28.84
Low
$22.22
Now
$19.34
High
$36.75

OMDA earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 5 of the last 5 quarters, by 182.3% on average.

  1. Q2 FY25: reported -$0.24 per share against an estimate of -$0.255
  2. Q3 FY25: reported -$0.06 per share against an estimate of -$0.0778
  3. Q4 FY25: reported $0.08 per share against an estimate of -$0.0523
  4. Q1 FY26: reported -$0.05 per share against an estimate of -$0.0818
  5. Q2 FY26: reported $0.08 per share against an estimate of -$0.0163

OMDA news

  • Press releaseGlobe Newswire

    Omada Health to Present Updated Long-Term Financial Targets at Inaugural Investor Day

  • 12 Health Care Stocks Moving In Wednesday's After-Market Session

  • Press releaseGlobe Newswire

    Omada Health to Host its First Investor Day on September 10, 2026

  • Press releaseGlobe Newswire

    Omada Health to Participate in Canaccord Genuity’s 46th Annual Growth Conference

  • Press releasePRNewswire

    DiMe convenes payers and virtual-first care providers to close the operational gap that leaves contracted virtual care providers invisible to patients

  • Press releaseGlobe Newswire

    Omada Health to Participate in Goldman Sachs Global Healthcare Conference

  • 12 Health Care Stocks Moving In Thursday's After-Market Session

  • Assessing Omada Health: Insights From 4 Financial Analysts

Similar companies

Companies in the same industry as Omada Health

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.